TipRanks
Safe Orthopaedics SA (FR:ALSAF)
:ALSAF
France Market
ALSAF
Safe Orthopaedics
RESEARCH TOOLSreports

Safe Orthopaedics (ALSAF) Ratios

0 Followers

Safe Orthopaedics Ratios

FR:ALSAF's free cash flow for Q4 2024 was €―. For the 2024 fiscal year, FR:ALSAF's free cash flow was decreased by € and operating cash flow was €―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.41 0.41 ― 0.03 0.74
Quick Ratio
 0.26 0.26 ― 0.02 0.38
Cash Ratio
 0.02 0.02 ― <0.01 0.02
Solvency Ratio
 -0.13 -0.18 ― -0.72 -0.34
Operating Cash Flow Ratio
 0.00 -0.10 ― >-0.01 -0.44
Short-Term Operating Cash Flow Coverage
 0.00 -0.16 ― >-0.01 -1.27
Net Current Asset Value
€ -14.08M€ -14.08M€ ―€ -271.82M€ -8.54M
Leverage Ratios
Debt-to-Assets Ratio
 1.14 1.14 ― 3.48 0.60
Debt-to-Equity Ratio
 -1.26 -1.26 ― -1.34 -7.73
Debt-to-Capital Ratio
 4.78 4.78 ― 3.94 1.15
Long-Term Debt-to-Capital Ratio
 0.00 0.00 ― >-0.01 1.59
Financial Leverage Ratio
 -1.11 -1.11 ― -0.39 -12.91
Debt Service Coverage Ratio
 -0.59 -0.27 ― -0.75 -1.21
Interest Coverage Ratio
 -22.19 0.00 ― -36.60 -16.79
Debt to Market Cap
 109.84 40.22 ― 72.63 0.01
Interest Debt Per Share
 76.81 74.60 ― 3.58M 141.41K
Net Debt to EBITDA
 -1.70 -3.75 ― -1.01 -1.70
Profitability Margins
Gross Profit Margin
-51.07%0.00%―74.41%-74.36%
EBIT Margin
-164.78%-64.81%―-4666.06%-112.76%
EBITDA Margin
-142.52%-64.81%―-4615.68%-95.96%
Operating Profit Margin
-164.78%-64.81%―-137.31%-101.72%
Pretax Profit Margin
-93.59%0.00%―-4669.81%-118.82%
Net Profit Margin
-75.93%-75.93%―-3536.04%-118.84%
Continuous Operations Profit Margin
-93.59%0.00%―-3536.04%-118.84%
Net Income Per EBT
81.12%0.00%―75.72%100.01%
EBT Per EBIT
56.80%0.00%―3400.80%116.81%
Return on Assets (ROA)
-34.72%-34.72%―-263.64%-42.17%
Return on Equity (ROE)
31.27%38.39%―101.53%544.57%
Return on Capital Employed (ROCE)
100.71%39.62%―4.04%-146.49%
Return on Invested Capital (ROIC)
-218.30%0.00%―-8.50%-67.12%
Return on Tangible Assets
-35.57%-35.57%―-263.68%-47.91%
Earnings Yield
-3539.36%-1294.40%―-5535.31%-1.24%
Efficiency Ratios
Receivables Turnover
 1.90 1.90 ― 2.58 2.01
Payables Turnover
 1.01 0.00 ― 0.70 2.85
Inventory Turnover
 1.79 0.00 ― 0.35 2.27
Fixed Asset Turnover
 2.69 2.69 ― 1.63 1.11
Asset Turnover
 0.46 0.46 ― 0.07 0.35
Working Capital Turnover Ratio
 -0.37 -0.47 ― -0.04 -2.94
Cash Conversion Cycle
 34.11 192.44 ― 671.92 214.49
Days of Sales Outstanding
 192.44 192.44 ― 141.48 181.60
Days of Inventory Outstanding
 204.40 0.00 ― 1.05K 161.05
Days of Payables Outstanding
 362.72 0.00 ― 520.38 128.16
Operating Cycle
 396.83 192.44 ― 1.19K 342.65
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -11.12 ― -14.97K -75.52K
Free Cash Flow Per Share
 0.00 -11.90 ― -15.70K -87.36K
CapEx Per Share
 0.00 0.77 ― 737.81 11.85K
Free Cash Flow to Operating Cash Flow
 0.00 1.07 ― 1.05 1.16
Dividend Paid and CapEx Coverage Ratio
 0.00 -14.38 ― -20.29 -6.38
Capital Expenditure Coverage Ratio
 0.00 -14.38 ― -20.29 -6.38
Operating Cash Flow Coverage Ratio
 0.00 -0.15 ― >-0.01 -0.55
Operating Cash Flow to Sales Ratio
 0.00 -0.37 ― -0.20 -0.93
Free Cash Flow Yield
0.00%-679.72%―-32.12%-1.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.01 -0.08 ― -0.02 -80.81
Price-to-Sales (P/S) Ratio
 0.02 0.06 ― 0.64 96.03
Price-to-Book (P/B) Ratio
 -0.01 -0.03 ― -0.02 -440.05
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -0.15 ― -3.11 -88.94
Price-to-Operating Cash Flow Ratio
 0.00 -0.16 ― -3.27 -102.89
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 ― >-0.01 -21.18
Price-to-Fair Value
 -0.01 -0.03 ― -0.02 -440.05
Enterprise Value Multiple
 -1.72 -3.84 ― -1.02 -101.78
Enterprise Value
 13.23M 13.43M ― 274.14M 572.41M
EV to EBITDA
 -1.72 -3.84 ― -1.02 -101.78
EV to Sales
 2.45 2.49 ― 47.18 97.66
EV to Free Cash Flow
 0.00 -6.24 ― -229.98 -90.46
EV to Operating Cash Flow
 0.00 -6.67 ― -241.32 -104.65
Tangible Book Value Per Share
 -60.57 -60.57 ― -2.67M -44.98K
Shareholders’ Equity Per Share
 -59.00 -59.00 ― -2.67M -17.66K
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 ― 0.24 >-0.01
Revenue Per Share
 29.83 29.83 ― 76.55K 80.91K
Net Income Per Share
 -22.65 -22.65 ― -2.71M -96.15K
Tax Burden
 0.81 0.00 ― 0.76 1.00
Interest Burden
 0.57 0.00 ― 1.00 1.05
Research & Development to Revenue
 0.00 0.00 ― 0.00 0.00
SG&A to Revenue
 0.02 0.00 ― 0.05 0.05
Stock-Based Compensation to Revenue
 0.00 0.00 ― <0.01 0.00
Income Quality
 0.00 0.43 ― <0.01 0.79
Currency in EUR